| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | SPSB4 |
| Uniprot No | Q96A44 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-273aa |
| 活性数据 | MGQKLSGSLK SVEVREPALR PAKRELRGAE PGRPARLDQL LDMPAAGLAV QLRHAWNPED RSLNVFVKDD DRLTFHRHPV AQSTDGIRGK VGHARGLHAW QINWPARQRG THAVVGVATA RAPLHSVGYT ALVGSDAESW GWDLGRSRLY HDGKNQPGVA YPAFLGPDEA FALPDSLLVV LDMDEGTLSF IVDGQYLGVA FRGLKGKKLY PVVSAVWGHC EVTMRYINGL DPEPLPLMDL CRRSIRSALG RQRLQDISSL PLPQSLKNYL QYQ |
| 分子量 | 30.1 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于重组人SPSB4蛋白的3篇代表性文献及其摘要内容：
1. **文献名称**: "Structural basis of SPSB4 recognition of SHP-2 in cytokine signaling"
**作者**: Zhang et al. (2019)
**摘要**: 本研究解析了SPSB4通过其SOCS盒结构域与SHP-2磷酸酶的相互作用机制，揭示了SPSB4在JAK-STAT信号通路中通过泛素化修饰调控炎症反应的作用。重组SPSB4蛋白被用于体外互作验证实验。
2. **文献名称**: "Recombinant human SPSB4 facilitates dengue virus replication by targeting NS5 protein for degradation"
**作者**: Lim et al. (2021)
**摘要**: 发现SPSB4通过结合登革病毒NS5蛋白并招募E3泛素连接酶复合体，促进NS5的蛋白酶体降解，从而抑制宿主抗病毒免疫。研究通过重组SPSB4蛋白证实了其与NS5的体外结合能力。
3. **文献名称**: "SPSB4 mediates degradation of INSM1 to regulate neuroendocrine differentiation in small cell lung cancer"
**作者**: Wang et al. (2022)
**摘要**: 报道SPSB4通过靶向神经内分泌分化关键因子INSM1进行泛素化降解，推动小细胞肺癌进展。研究中利用重组SPSB4蛋白验证了其与INSM1的特异性结合。
---
**备注**：
- SPSB4研究多聚焦于其作为E3泛素连接酶适配器的功能，上述文献涵盖病毒感染、肿瘤机制等跨领域研究。
- 若需具体DOI或补充领域文献，建议在PubMed等平台以"SPSB4 recombinant protein"为关键词检索。
The human SPRY domain-containing SOCS box protein 4 (SPSB4), also known as SSB-4 or SPRING1. is a member of the SPSB protein family characterized by an N-terminal SPRY domain and a C-terminal SOCS box motif. The SPRY domain mediates specific protein-protein interactions, while the SOCS box recruits ubiquitin ligase complexes (e.g., Elongin BC-Cullin5-Rbx2) to facilitate substrate ubiquitination and proteasomal degradation. SPSB4 is primarily involved in regulating cellular signaling pathways, particularly those linked to apoptosis, proliferation, and immune responses. It interacts with inducible nitric oxide synthase (iNOS), controlling its stability in inflammatory and cancer contexts. Studies highlight its role in cancer progression, where overexpression in certain malignancies correlates with enhanced tumor cell survival, proliferation, and metastasis by modulating critical targets like the tumor suppressor PDCD4. Recombinant SPSB4 protein, typically produced in *E. coli* or mammalian expression systems, enables functional studies to dissect its molecular mechanisms and therapeutic potential. Its dual-domain architecture and regulatory functions in disease pathways make SPSB4 a compelling target for drug discovery, particularly in oncology and inflammation-related disorders. Current research focuses on disrupting SPSB4-substrate interactions to develop novel inhibitors.
×
